Insider Transactions in Q4 2023 at Idexx Laboratories Inc (IDXX)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 07
2023
|
James F Polewaczyk Executive Vice President |
SELL
Open market or private sale
|
Direct |
11,636
-17.16%
|
$6,062,356
$521.76 P/Share
|
Dec 07
2023
|
James F Polewaczyk Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
11,636
+24.19%
|
$2,874,092
$247.86 P/Share
|
Dec 04
2023
|
Jonathan W Ayers Director |
SELL
Bona fide gift
|
Direct |
2,424
-0.88%
|
-
|
Dec 04
2023
|
Jonathan Jay Mazelsky President and CEO |
SELL
Open market or private sale
|
Direct |
7,128
-4.18%
|
$3,656,664
$513.23 P/Share
|
Dec 04
2023
|
Jonathan Jay Mazelsky President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,424
+13.45%
|
$1,060,496
$79.54 P/Share
|
Nov 29
2023
|
Jonathan W Ayers Director |
SELL
Bona fide gift
|
Direct |
1,850
-0.67%
|
-
|
Nov 20
2023
|
Jonathan W Ayers Director |
SELL
Bona fide gift
|
Direct |
2,506
-0.9%
|
-
|
Nov 15
2023
|
Jonathan W Ayers Director |
SELL
Bona fide gift
|
Direct |
2,494
-0.88%
|
-
|
Nov 07
2023
|
Michael Lane Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,728
+10.02%
|
$222,912
$129.24 P/Share
|
Oct 30
2023
|
Daniel M Junius Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.62%
|
$7,524
$396.39 P/Share
|